Page 26 - Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Aug 09, 2024

Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

831 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ATRA

Atara Biotherapeutics
US$7.58-16.4%-85.5%US$36.9mUS$104.00PS1.1xE45.5%n/a

LGVN

Longeveron
US$2.50-13.5%-92.4%US$36.6mUS$11.32PS36.7xE25.6%n/a

RPID

Rapid Micro Biosystems
US$0.856.9%-8.4%US$36.5mUS$8.00PS1.5xE24.4%n/a

CYTH

Cyclo Therapeutics
US$1.2717.6%-16.4%US$34.6mUS$3.20PS32.3xE54.3%n/a

BNGO

Bionano Genomics
US$0.39-28.6%-90.1%US$34.6mUS$4.40PB0.4xE65.4%n/a

MRKR

Marker Therapeutics
US$3.80-13.5%-20.1%US$34.4mUS$11.00PS10.2xE-17.2%n/a

BTAI

BioXcel Therapeutics
US$0.73-26.2%-90.1%US$33.4mUS$6.25PS12.4xE17.1%n/a

AADI

Aadi Bioscience
US$1.39-0.7%-76.5%US$33.2mUS$10.00PS1.4xE40.5%n/a

IMRX

Immuneering
US$1.09-18.0%-89.3%US$33.2mUS$11.07PB0.5xE-10.9%n/a

IXHL

Incannex Healthcare
US$2.0712.7%-68.6%US$33.0mn/aPE1.7xn/an/a

OKYO

OKYO Pharma
US$0.996.1%-26.3%US$32.9mUS$7.00PE-2.5xE-6.7%n/a

NLTX

Neoleukin Therapeutics
US$13.964.5%59.5%US$32.8mn/aPB0.4xn/an/a

NRBO

NeuroBo Pharmaceuticals
US$3.60-9.7%-27.3%US$32.1mUS$27.67PB3xE-16.9%n/a

CUE

Cue Biopharma
US$0.64-12.9%-79.0%US$32.1mUS$5.00PS4.4xE13.8%n/a

ACHL

Achilles Therapeutics
US$0.77-2.0%-22.1%US$32.0mUS$4.13PB0.2xE-21.0%n/a

INKT

MiNK Therapeutics
US$0.79-9.5%-56.8%US$31.9mUS$8.00PE-1.5xE38.9%n/a

XLO

Xilio Therapeutics
US$0.87-3.1%-69.0%US$31.7mUS$4.67PS13.6xE-24.7%n/a

AGE

AgeX Therapeutics
US$11.10-23.6%-48.7%US$31.5mn/aPS195.5xn/an/a

MIRA

MIRA Pharmaceuticals
US$2.10-3.2%-69.3%US$31.3mUS$12.50PB9.8xE13.0%n/a

ISO

IsoPlexis
US$0.760.07%-80.6%US$30.3mUS$1.70PS1.8xE43.9%n/a

INAB

IN8bio
US$0.70-11.5%-40.3%US$30.2mUS$7.66PB1.8xE1.5%n/a

ANGN

Angion Biomedica
US$1.0017.7%-37.9%US$30.1mn/aPS46.1xS-122.1%n/a

ACXP

Acurx Pharmaceuticals
US$1.88-10.9%3.1%US$30.1mUS$10.88PB5xE8.1%n/a

QNCX

Quince Therapeutics
US$0.69-1.4%-43.4%US$29.8mn/aPB0.4xn/an/a
Page 26 of 35
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.